Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
ERGIC3
Introduction
Endoplasmic reticulum-Golgi intermediate compartment protein 3 is a protein that in humans is encoded by the ERGIC3 gene.[1][2] It has been reported to be regulated by micro RNAs and may be important in a cancer.[3][4]
References
References
- ↑ Lai CH, Chou CY, Ch’ang LY, Liu CS, Lin W (Aug 2000). “Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics”. Genome Res. 10 (5): 703–13. doi:10.1101/gr.10.5.703. PMC 310876. PMID 10810093.
- ↑ “Entrez Gene: ERGIC3 ERGIC and golgi 3”.
- ↑ Zhang, Ling-yun; Liu, Min; Li, Xin; Tang, Hua (2013). “miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3)”. Journal of Biological Chemistry. 288 (6): 4035–4047. doi:10.1074/jbc.M112.410506. ISSN 0021-9258. PMC 3567655.
- ↑ Lin, Qing-Hai; Zhang, Kui-Dong; Duan, He-Xian; Liu, Min-Xia; Wei, Wan-Li; Cao, Yi (2015). “ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancer”. Cancer Science. 106 (10): 1463–1473. doi:10.1111/cas.12741. ISSN 1347-9032.
Further reading
Further reading
- Deloukas P, Matthews LH, Ashurst J, et al. (2002). “The DNA sequence and comparative analysis of human chromosome 20”. Nature. 414 (6866): 865–71. doi:10.1038/414865a. PMID 11780052.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Scanlan MJ, Gout I, Gordon CM, et al. (2003). “Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression”. Cancer Immun. 1: 4. PMID 12747765.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Breuza L, Halbeisen R, Jenö P, et al. (2004). “Proteomics of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies ERGIC-32, a new cycling protein that interacts with human Erv46”. J. Biol. Chem. 279 (45): 47242–53. doi:10.1074/jbc.M406644200. PMID 15308636.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Otsuki T, Ota T, Nishikawa T, et al. (2007). “Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries”. DNA Res. 12 (2): 117–26. doi:10.1093/dnares/12.2.117. PMID 16303743.
- Nishikawa M, Kira Y, Yabunaka Y, Inoue M (2007). “Identification and characterization of endoplasmic reticulum-associated protein, ERp43”. Gene. 386 (1–2): 42–51. doi:10.1016/j.gene.2006.06.030. PMID 17020792.